D-0398-2021 Class I Terminated
FDA drug recall D-0398-2021 was initiated by Acella Pharmaceuticals, LLC on Apr 29, 2021 and is designated Class I. Reason for recall: Subpotent Drug The recall status is terminated (terminated Mar 13, 2024). Affected quantity: 79,344 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 2, 2021
- Initiation Date
- Apr 29, 2021
- Termination Date
- Mar 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 79,344 bottles
Product description
NP Thyroid 90 Thyroid Tablets, USP 1&1/2 grain (90 mg) 100-count bottles, Rx only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-331-01
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the United States including Puerto Rico
Code information
Lots: M331J19-10A, M331J19-11, M331J19-2A, M331J19-6A, Exp. 08/31/2021, M331K19-1, M331K19-2, M331K19-6, Exp. 09/30/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0398-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026